Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06509906
Title M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
Acronym DDRiver 511
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at Health One NOT_YET_RECRUITING Denver Colorado 80218 United States Details
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center RECRUITING Pennington New Jersey 08534 United States Details
Vanderbilt University - 150912667 NOT_YET_RECRUITING Nashville Tennessee 37232 United States Details
The University of Texas MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030-4009 United States Details
Cancer Research SA NOT_YET_RECRUITING Elizabeth Vale Australia Details
St George Private Hospital NOT_YET_RECRUITING Kogarah Australia Details
Peter MacCallum Cancer Centre - Use the one with Account 2 VCCC NOT_YET_RECRUITING Parkville Australia Details
National Cancer Center Hospital NOT_YET_RECRUITING Chuo-ku Japan Details
Samsung Medical Center RECRUITING Seoul Korea, Republic of Details
Seoul National University Hospital RECRUITING Seoul Korea, Republic of Details
NEXT Barcelona - NEXT Barcelona NOT_YET_RECRUITING Barcelona Spain Details
NEXT Madrid - Hospital Universitario Quironsalud Madrid NOT_YET_RECRUITING Pozuelo de Alarcon Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field